Immunology
Case Reports
52-year-old man • intermittent fevers • recently received second dose of COVID-19 vaccine • tremors in all 4 extremities • Dx?
► Intermittent fevers
► Recently received second dose of COVID-19 vaccine
► Tremors in all 4 extremities
From the Journals
Maternal pertussis vax effective for infants in most vulnerable months
Large study also helps answer questions on duration of effectiveness and the potential “blunting” effect in infants.
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Latest News
FDA issues letter regarding lebrikizumab review for atopic dermatitis
The agency cited concerns related to an inspection of a third-party contract manufacturer.
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...
From the Journals
Many young people stop ulcerative colitis maintenance treatment, risking relapse
Globally, the incidence of UC is increasing fastest in younger populations. It’s estimated that up to 30% of individuals with UC are diagnosed in...
Feature
Are ketogenic supplements the key to healthy aging?
Drawbacks of the initial formulations of ketone esters, first developed 20 years ago, included high cost and terrible taste.
From the Journals
People with long COVID have specific blood biomarkers, study says
The findings may be a step toward creating blood tests to positively identify people with long COVID so specialized treatments can be employed.
Latest News
Primary care clinicians should spearhead HIV prevention
U.S. Preventive Services Task Force guidelines call for clinicians to prescribe pre-exposure prophylaxis drugs to adolescents and adults who do...
Latest News
It’s back to school for asthma, too
A more relaxed approach to maintenance therapy for the condition over the summer holidays and exposure to allergens at school contribute to this...
Latest News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.